EU approves use of Pfizer-BioNTech vaccine in children 12 and over in Europe

EU approves use of Pfizer-BioNTech vaccine in children 12 and over in Europe

The European Commission authorised the use of the Pfizer-BioNTech vaccine in 12- to 15-year-olds on Friday, following the European Medicines Agency's approval of administering the jabs to adolescents earlier in the day.

Norway ‘disagreed’ with EMA conclusion over AstraZeneca vaccine

Norway ‘disagreed’ with EMA conclusion over AstraZeneca vaccine

Norway to retain suspension of AstraZeneca vaccine until at least next week

Norway to retain suspension of AstraZeneca vaccine until at least next week

AstraZeneca vaccine ‘safe and effective’ against Covid-19, European Medicines Agency concludes

AstraZeneca vaccine ‘safe and effective’ against Covid-19, European Medicines Agency concludes